A rogue set of “zombie” immune cells may be driving aging and fatty liver disease by flooding tissues with inflammation.

Oxford, UK – 16th April 2026 - Alethio Therapeutics, a biopharmaceutical company developing novel treatments for myeloproliferative neoplasms ...

Matthias Matthijs’s career has spanned academia and think tanks. He sat down with CFR to discuss the benefits of observing ...

Growing up with Tiger Woods as a dad meant being in the spotlight from an early age, but Sam Woods handled it with grace, ...

Explore 2026 CLL frontline choices, from all-oral acalabrutinib–venetoclax to MRD-guided care, plus pipeline advances and ...

This feature explores the technical reality behind common beauty-tech misconceptions. By shifting the focus from marketing ...

Scientists created a definitive E3 ligase atlas, resolving inconsistencies and enabling better disease research and drug ...

Dr. Gitanjaly Chhabra and Dr. Kathleen Hare from University Canada West explore the transformative potential of AI in IVF ...

Spread the loveThe global food landscape is evolving at an unprecedented pace, as traditional agricultural practices face challenges from climate change, population growth, and resource scarcity. A ...

Abstract: This article investigates the impacts of the disruptive periods of uncertainty and great change caused by processes such as the 2020 global Covid-19 pandemic, on the performing arts industry ...

As biologists know, nature can take its sweet time explaining itself. Andrew Gillis, associate scientist at the Marine ...